Two Sigma Advisers
KRSA

Two Sigma Advisers’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Two Sigma Advisers’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,043
Closed -$35.9K – 557
2025
Q4 		$35.9K Buy
+4,043
New +$7.22K ﹤0.01% 2293
2023
Q2 		– Sell
-129
Closed -$7.81K – 2439
2023
Q1 		$7.81K Sell
129
-41
-24% -$517 ﹤0.01% 2555
2022
Q4 		$15.6K Sell
170
-91
-35% -$1.08K ﹤0.01% 2443
2022
Q3 		$31K Sell
261
-430
-62% -$7.39K ﹤0.01% 2414
2022
Q2 		$53K Sell
691
-845
-55% -$12.1K ﹤0.01% 2471
2022
Q1 		$239K Sell
1,536
-2,188
-59% -$52.7K ﹤0.01% 2324
2021
Q4 		$897K Sell
3,724
-902
-19% -$42.6K ﹤0.01% 1616
2021
Q3 		$1.99M Buy
4,626
+2,294
+98% +$150K 0.01% 1259
2021
Q2 		$1.27M Buy
2,332
+1,119
+92% +$70.1K ﹤0.01% 1526
2021
Q1 		$474K Buy
1,213
+809
+200% +$60.8K ﹤0.01% 2033
2020
Q4 		$173K Buy
+404
New +$27.5K ﹤0.01% 2201

Other funds holding KRSA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Two Sigma Advisers's KRSA Position: Q1 2026 in Review

Two Sigma Advisers sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q1 2026, closing a stake of 4,043 shares — an estimated $35.9K sold.

Two Sigma Advisers first reported a position in KRSA in Q4 2020 and held it in 11 quarters. The position peaked at $1.99M in Q3 2021. 16 funds tracked by Wall St. Rank hold KRSA as of Q1 2026.

  • Two Sigma Advisers reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 4,043 Korsana Biosciences, Inc. Common Stock shares in Q1 2026, an estimated $35.9K.
  • Two Sigma Advisers first reported a position in Korsana Biosciences, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • Two Sigma Advisers's Korsana Biosciences, Inc. Common Stock position peaked at $1.99M in Q3 2021.
  • 16 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.